Eli Lilly and Company (LLY.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In EUR
| Market Cap | 965.63B |
| Enterprise Value | 1T |
| P/E Ratio | 39.14 |
| PEG Ratio | 0.3 |
| Price/Sales Ratio | 14.39 |
| Price/Book Ratio | 31.64 |
| Enterprise/Revenue | 14.92 |
| Enterprise/EBITDA | 32.2 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.35 |
| Operating Margin | 0.46 |
| Return On Assets | 0.22 |
| Return On Equity | 1.01 |
| Revenue | 65.18B |
| Revenue/Share | 80.77 |
| Gross Profit | 54.62B |
| EBITDA | 31.69B |
| Net Income | 20.64B |
| Diluted EPS | 22.95 |
| Total Cash | 5.26B |
| Total Cash/Share | 5.9 |
| Total Debt | 43.21B |
| Total Debt/Equity | 1.39 |
| Current Ratio | 1.5 |
| Book Value Per Share | 34.88 |
| 52-Week Change | 45.63 |
| 52-Week High | 1,034 |
| 52-Week Low | 535.8 |
| Moving Average 50 Days | 873.39 |
| Moving Average 200 Days | 839.24 |
| Average Volume | 1,443 |
| Shares Outstanding | 941.74M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 6.46 |
| Trailing Annual Dividend Yield | 0.59 |
| Payout Ratio | 0.22 |
| Last Split Factor | N/A |
| Last Split Date | N/A |